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ABSTRACT
Genomic integrity is preserved by the action of
protein complexes that control DNA homeostasis.
These include the sliding clamps, trimeric protein
rings that are arranged around DNA by clamp
loaders. Replication factor C (RFC) is the clamp
loader for proliferating cell nuclear antigen, which
acts on DNA replication. Other processes that
require mobile contact of proteins with DNA use
alternative RFC complexes that exchange RFC1 for
CTF18 or RAD17. Phosphoinositide 3-kinases
(PI3K) are lipid kinases that generate 3-poly-
phosphorylated-phosphoinositides at the plasma
membrane following receptor stimulation. The two
ubiquitous isoforms, PI3Kalpha and PI3Kbeta, have
been extensively studied due to their involvement in
cancer and nuclear PI3Kbeta has been found to
regulate DNA replication and repair, processes
controlled by molecular clamps. We studied here
whether PI3Kbeta directly controls the process of
molecular clamps loading. We show that PI3Kbeta
associated with RFC1 and RFC1-like subunits. Only
when in complex with PI3Kbeta, RFC1 bound to Ran
GTPase and localized to the nucleus, suggesting
that PI3Kbeta regulates RFC1 nuclear import.
PI3Kbeta controlled not only RFC1– and RFC–
RAD17 complexes, but also RFC–CTF18, in turn af-
fecting CTF18-mediated chromatid cohesion.
PI3Kbeta thus has a general function in genomic
stability by controlling the localization and function
of RFC complexes.
INTRODUCTION
DNA structure remodeling events occur during DNA
replication, repair and chromatin cohesion. Failure of
any of these processes can promote genomic instability,
characteristic of age-associated diseases and of cancer
cells (1,2). To prevent this, cells use various protein
complexes including helicases, replicases, polymerases,
clamps and clamp loaders, which recruit appropri-
ate machinery to chromatin for DNA maintenance
processes.
Ring-type polymerases (found in all organisms) are
formed by three components: the DNA polymerase, a
trimeric protein ring (called sliding clamp) and the
clamp–loader complex. PCNA (proliferating cell nuclear
antigen) is the ﬁrst described sliding clamp in eukaryotes
that acts as a mobile platform for the DNA polymerases d
and e during DNA replication; it is arranged in its trimeric
structure around DNA by the clamp loader RFC (repli-
cation factor C) (reviewed in 3–9).
RFC consists of ﬁve subunits, one large (RFC1) and
four small (RFC2–5). All subunits share two structurally
conserved domains that comprise an ATPase module of
the AAA+ family. The large subunit, RFC1, also has
extended N- (NT) and C-terminal (CT) regions (10,11).
The NT region includes a conserved PCNA-binding
motif that targets RFC to replication factories (10). The
RFC1 CT domain (CTD) is less well characterized,
although mutation experiments and structural analyses
point to a role for CTD in RFC complex assembly and
stability (10,11). Three additional RFC-like complexes are
critical for other cellular processes; in these, the RFC1
subunit is replaced by Elg1 (RFC–Egl1), RAD17 (RFC–
RAD17) or CTF18 (RFC–CTF18) (4). RFC and
RFC-like complexes act as platforms for sliding clamp
arrangement around DNA; all RFC are able to load
PCNA-containing complexes onto DNA, but they act in
distinct complexes and cellular situations, resulting in
the function of RFC–Egl1 in genome stability, RFC–
RAD17 in DNA repair, and RFC–CTF18 in chromatid
cohesion (4,12–14).
The class I phosphoinositide 3-kinases (PI3K) are
lipid kinases that catalyse in vivo production of
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phosphatidylinositols (PI)(3,4,5)P3 and PI(3,4)P2 at the
plasma membrane. The PI3K are heterodimeric proteins
consisting of a p110 catalytic (p110a, p110b or p110d) and
a p85 regulatory subunit; p110g is structurally similar, but
associates to distinct regulatory subunits (15–17). Whereas
p110d and p110g are more abundant in hematopoietic
cells and control the immune response (17), the catalytic
subunits p110a and p110b are expressed ubiquitously and
control cell division and cancer (18). p110a and p110b
isoforms have distinct subcellular localizations and differ-
ent functions (19–22). The classical function of PI3K is
the generation of poly-phosphoinositides at the cell
membrane; this is the case for p110a, which is found
mainly in the cytosol and regulates insulin action and
cell cycle entry. p110b also exerts this action but is more
abundant in the nucleus, associates with PCNA and
RAD17, and participates in DNA replication and repair
(22–24).
Here we studied whether p110b regulates DNA homeo-
stasis by controlling molecular clamp loading onto chro-
matin. We show that p110b associates directly with
RFC1-like subunits and is necessary for RFC complex
formation and function. Indeed, p110b association with
RFC1-like subunits was needed for RFC, RFC–RAD17
and RFC–CTF18 complex assembly and function. In
addition to controlling DNA replication and repair,
p110b-regulated chromatin cohesion, supporting a
general function in higher eukaryotes for p110b in the
regulation of sliding clamp binding to chromatin. One
mechanism by which p110b mediates this action is by
regulating RFC1 nuclear import.
MATERIALS AND METHODS
Cell lines, cell culture and plasmids
U2OS, NIH3T3 and 293T cell lines were maintained in
Dulbecco’s modiﬁed Eagle’s medium (Gibco-BRL) sup-
plemented with 10% fetal bovine serum, 2mM glutamine,
10mM HEPES, 100 IU/ml penicillin and 100 mg/ml
streptomycin.
Untagged wild type (WT)-p110b was donated by
B. Vanhaesebroeck (Barts Cancer Institute, Cancer
Research UK, London, UK). pSG5-myc-K805R-hp110b,
-p110a and -p110b have been described (22).
pCDNA3-Flag-RFC1, -RFC4 and -CTF18 were a gift of
T. Todo (Kyoto University, Japan). pCDNA3-PCNA was
donated by M. C. Cardoso (Max-Delbru¨ck-Centrum,
Berlin, Germany), RAD9 by H. G. Wang (Mofﬁtt Cancer
Center and Research Institute, Tampa, FL), and Flag-Ran
and Flag-Q69L-Ran were from R. Pulido (Centro de
Investigacio´n Prı´ncipe Felipe de Valencia, Spain). pET28-
His-importin (Imp)-b was from R. A. Cerione (Cornell
University, Ithaca, NY). Myc-p110b-mutant 1, -mutant 2
and the Flag-RFC1-mutant were generated using
QuikChange site-directed mutagenesis (Stratagene) with
appropriate oligonucleotides. shRNA for murine PI3K,
RFC1 and RFC4 subunits and control-scrambled shRNA
were custom-made (Origene Technologies). siRNA for
human PI3K subunits or scrambled siRNA were
custom-made (Invitrogen).
Antibodies and reagents
Western blot (WB) and immunoprecipitation (IP) assays
were probed with the following antibodies: anti-Myc
tag (9B11), -p-Chk-1 (Ser345), -p110b (all from Cell
Signaling), anti-histone from Upstate Biotechnology
(Millipore), -CenpA (Abcam), and anti-Flag, -b-actin
and -tubulin from Sigma-Aldrich. Anti-p110a was
donated by A. Klippel (Merck, Boston, MA).
Anti-RFC1, -RFC4, -RAD17, -CTF18, -SMC1, -RAD9
and -cyclin B were from Santa Cruz Biotechnology,
anti-PCNA from BD Transduction Labs, anti-His mAb
from Clontech, Alexa488- and Cy3-labeled secondary
antibodies from Molecular Probes, HRP-conjugated sec-
ondary antibodies from Dako and ECL from GE
Healthcare. Colcemid was from Gibco-BRL. PIK75 and
TGX221 were previously described (22).
IF, WB, IP and glycerol gradient
WB and IP were as described (22). For immunoﬂuores-
cence (IF), cells were plated on cover slips and ﬁxed with
4% formaldehyde [10 min, room temperature (RT)], then
permeabilized with 0.3% Triton X-100 in PBS staining
buffer (10min), incubated with blocking buffer (0.1%
TX-100, 3% BSA in PBS; 30min), followed by incubation
with primary antibody (1 h, RT, with end-to-end rocking).
Unbound antibody was removed by washing cells three
times with blocking buffer, and cells were incubated with
appropriate secondary antibody (1:500, 1 h, RT). Samples
were washed three times with blocking buffer and
incubated with Vectashield mounting medium (Vector
Laboratories); DAPI was used to stain DNA. Images
were captured on a confocal ﬂuorescence microscope
with an Olympus FluoView (Olympus).
For glycerol gradients, NIH3T3 cell lysates prepared
as above were loaded on an 8ml gradient of 15–35%
glycerol in buffer H (25mM Hepes, 0.1mM EDTA,
15% glycerol, 1mM dithiothreitol (DTT), 1mM PMSF)
containing 0.1M NaCl and centrifuged (234 100g in a
SW41 rotor (Beckman Coulter), 20 h at 4C. Fractions
(0.5ml) were collected from the top and proteins analysed
by WB. Standard sedimentation markers were loaded
in parallel glycerol gradients to determine sedimentation
position (25).
In vitro transcription/translation
cDNAs were transcribed and translated in vitro in the pres-
ence of 35S methionine using the TNT T7-coupled reticu-
locyte lysate system (Promega). In other experiments,
Flag-RFC1 was transcribed and translated with
Flag-Ran. In vitro binding of proteins was analysed by
IP of Flag or Myc tags, or with anti-RFC1 or -Ran Ab,
SDS-PAGE and autoradiography.
Transfection, subcellular fractionation and Ran
pulldown assay
Cells were transfected with Lipofectamine Plus (Qbiogene)
and cultured 48 h prior to analysis. For siRNA transfec-
tion, we used Lipofectamine Max (Qbiogene). For
subcellular fractionation, cells were cultured for indicated
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times/conditions and collected. Cytoplasmic, nuclear
and chromatin fractions were isolated as described (26).
Buffer A (10mM Hepes pH 7.9, 10mM KCl, 1.5mM
MgCl2, 0.34M sucrose, 10% glycerol, 1mM DTT) was
used for cytoplasmic extraction. Non-salt buffer for
nuclear extraction was 3mM EDTA, 0.2mM EGTA
and 1mM DTT; for chromatin, samples were boiled and
sonicated in Laemmli buffer and proteins extracted. In
all cases, samples were quantiﬁed by BCA protein assay
(Pierce) and same amount of protein analysed in WB.
For DNA damage experiments, we transfected cells with
different shRNAs. Cells were g-irradiated (MARK 1)
using a 137Cs probe, collected after 24 h and analysed
in WB.
For Ran pulldown assays, His6-Imp-b was expressed
in Escherichia coli. For the assay, NIH3T3 cells were
lysed and His6-Imp-b added to lysates (30min, RT).
The lysates with His6-Imp-b-bound proteins were
incubated with Ni-chelating agarose beads (ABT; 1 h,
4C, with rocking). The beads were pelleted, washed
three times with lysis buffer plus 100mM imidazole to
eliminate background binding of non-speciﬁc proteins,
and then resuspended in 5x Laemmli buffer for analysis
by SDS-PAGE and WB.
Cell cycle
Cell cycle distribution was examined by DNA staining
with propidium iodide and analysed by ﬂow cytometry
in a Cytomics FC500 (Beckman-Coulter). Cells were
synchronized at G0/G1 by serum deprivation (19 h).
After washing, cells were released by serum addition and
analysed at indicated times. For mitosis, cells were
synchronized by colcemid treatment (16 h), then cultured
in complete medium (1 h) and ﬁxed for IF, or enriched in
mitotic cells by shaking off the culture disk. For S phase
progression, cells were incubated with 10 mM BrdU
(90min), washed twice in fresh medium and harvested
at indicated times using trypsin-EDTA. Cells were ﬁxed
in ice-cold 80% methanol (overnight, 20C). Cells were
resuspended in 2 N HCl with 0.5% Triton X-100 and
pepsin (60min, 37C), washed twice with PBS, incubated
with anti-BrdU-FITC (1 h, 37C), washed again, and
incubated with propidium iodide (30min) and analysed
by ﬂow cytometry.
Electron microscopy
293T cells were transfected with Flag-RFC1 alone or with
p110b siRNA. For immunogold labeling assays, cells
cultured on coverslips (48 h) were ﬁxed in situ with 4%
paraformaldehyde (1 h, RT), permeabilized with
PBS+0.1% saponin (20min) and blocked in a mixture
of 2% BSA, 1% goat serum and 0.1% saponin in PBS
(20min). Primary antibody incubation with anti-Flag
(60min) was followed by incubation with goat-anti-mouse
IgG-Nanogold (1:40, 60min; Nanoprobes). Cells were
ﬁxed with 2.5% glutaraldehyde in PBS (60min), washed
with distilled water and silver-enhanced with HQ Silver
(Nanoprobes), then stained with uranyl acetate,
dehydrated in ethanol and embedded in epoxy resin
(Fluka). Inﬁltrated samples were polymerized (60C,
2 days). After polymerization, resin-containing cells were
separated from the coverslip by dipping into liquid nitro-
gen. Ultrathin sections (70 nm) were cut in parallel to the
monolayer, transferred to formvar-coated EM-buttonhole
grids and stained with aqueous uranyl acetate and lead cit-
rate. Images were captured on a Jeol JEM 1200 operating
at 100Kv.
Sequence structure alignments
Models of the RFC complex were derived using the RFC
crystal structure (PDB code: 1SXJ). p110b models were
designed from our previous molecular model (27) and
the published crystal structure (PDB code: 2Y3A).
Potential sequences involved in p110b-RFC1 interaction
were determined by BLAST search sequences in the NCBI
PDB database. We analysed residues conserved among
species in RFC1 and RFC1-like proteins. Similar
sequences in p110a, p110b and other DNA-related
proteins were proposed as RFC1-binding regions and can-
didate residues in RFC1 and p110b were screened in com-
putational models of RFC and p85b/p110b complexes.
Statistical analyses
Statistical analyses were performed using StatView 512+.
Fluorescence intensity was quantitated with ImageJ soft-
ware. Statistical signiﬁcance was evaluated with Student’s
t-test and the chi-square test calculated using Prism5 V.5.0
software. Error bars represent standard deviations of the
mean values.
RESULTS
Puriﬁed p110b associates directly to RFC1
p110b knockdown reduces the binding of PCNA and of
RAD9 to chromatin during DNA replication and repair
(23,24). Since PCNA and RAD9 are sliding clamps, we
sought to determine whether p110b affected molecular
clamp loading onto chromatin. We studied whether
p110b binds directly to molecular clamps or to clamp
loaders.
To examine the association between p110 and these
puriﬁed RFC subunits in vitro, we performed in vitro tran-
scription/translation of the two ubiquitous PI3K subunits
(p110a and p110b), and of RFC1, RFC4 and the
RFC1-like protein CTF18. Both p110a and p110b
(whose amino acid sequences are 42% identical) bound
RFC1 and CTF18 in vitro (Figure 1A). Translation efﬁ-
ciency of the RFC4+p110 reaction was similar to that of
RFC1+p110, near 1:1 (Figure 1A, left). Although IP of
p110 was able to pulldown an amount of RFC1 similar to
that of p110, it apparently failed to pulldown RFC4,
which was undetectable when p110 was clearly visible
(Figure 1A, right), suggesting inefﬁcient p110 association
with RFC4 (Figure 1A). Quantitation of the RFC1 or the
CTF18 signal in complex with p110 showed signiﬁcant
association levels (nearly 1:1; Figure 1A). Reciprocal
Flag-RFC IP assays detected p110a and p110b in
complex with RFC1 and CTF18, but not with RFC4
(Figure 1B). Puriﬁed p110a and p110b interacted with
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RFC1 in the absence of the PI3K p85 regulatory subunit,
indicating that p110 subunits themselves associate to
RFC1-like components.
p110b can also be isolated from cell extracts in complex
with the molecular clamps PCNA and RAD9 (23,24); we
tested whether p110b also associates directly to puriﬁed
PCNA or RAD9, as above. p110b did not bind directly to
PCNA or RAD9 (Figure 1C). Puriﬁed p110a and p110b
thus associated in vitro to the clamp loader components
RFC1 and CTF18, but not directly to the molecular
clamps PCNA and RAD9.
p110b controls RFC complex assembly and localization
To assess whether p110 interacts with RFC1-like subunits
in vivo, we analysed the association of endogenous proteins
in an immortal murine ﬁbroblast cell line (NIH3T3), and
conﬁrmed the results in a human tumor cell line (U2OS).
Both cell lines expressed RFC1 and RFC4 normally, and
expression was unaffected by p110a or p110b knockdown
with interfering RNA (Supplementary Figure S1A). IP of
RFC1 from U2OS or NIH3T3 cell lysates showed that
p110b, but not p110a, associated to RFC1 in vivo (Figure
2A). Conversely, anti-p110b antibodies (Ab), but not
anti-p110a Ab precipitated RFC1 (Figure 2A). Although
puriﬁed p110b did not associate directly with RFC4
(Figure 1A and B), we detected co-precipitation of RFC4
with p110b in cell extracts (Figure 2A), since RFC1 and
RFC4 both form part of the RFC complex. These results
show that p110b, but not p110a, interacts with the RFC
in vivo. We veriﬁed the status of native RFC1/p110b
complexes by glycerol gradient sedimentation. In total
extracts (not shown) and in nuclear extracts of U2OS
cells, p110b was detected in fractions in which RFC1 and
RFC4 were present (Figure 2B), validating the integrity of
RFC1/p110b complexes.
Since p110b associated directly to RFC1, to determine
whether p110b deletion affects RFC complex assembly,
we depleted NIH3T3 cells of p110b using a speciﬁc
shRNA. IP of RFC1 and detection of associated RFC4
in WB indicated that p110b depletion impaired RFC1/
RFC4 association, and in turn PCNA binding to chroma-
tin (Figure 2C). The reciprocal assay (RFC4 IP and
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(continued)
detection of associated RFC1) conﬁrmed that p110b
silencing abrogated RFC complex formation, determined
as RFC1/RFC4 association in NIH3T3 or U2OS
cells (Supplementary Figure S1B). In contrast, p110a de-
pletion did not affect RFC complex formation in vivo
(Supplementary Figure S1C).
We previously showed that p110b control of DNA rep-
lication is largely kinase-independent (23). To test whether
p110b interaction with RFC1 requires kinase activity, we
depleted NIH3T3 cells of p110b and analysed RFC1 and
p110b association after re-expression of WT or kinase
inactive p110b (K805R-p110b) (23). RFC1 association
with Myc-tagged-WT- or the KR-p110b mutant was
similar, although slightly less efﬁcient with KR-p110b
(Figure 2D). Cell treatment with a selective inhibitor of
p110b (23) only moderately reduced RFC1/p110b associ-
ation (Supplementary Figure S1D). These data suggest
that kinase activity is not essential for RFC1/p110b
interaction.
RFC anchorage to chromatin requires correct RFC
complex assembly (6); we hypothesized that since p110b
depletion impairs complex formation, it would reduce
RFC localization on DNA. We used fractionation
analysis to study the inﬂuence of p110b expression on
RFC localization; NIH3T3 cells transfected with p110b
shRNA were separated into cytoplasmic, nuclear and
chromatin fractions. p110b silencing reduced nuclear
and chromatin-bound RFC1 and RFC4, and also
reduced binding of the RFC1-like subunit Rad17 to chro-
matin (Figure 2E).
We tested whether the reduction in nuclear and
chromatin-bound RFC1 and RFC4 in p110b-depleted
NIH3T3 cells was also detectable by IF. RFC1 and
RFC4 are mainly nuclear (28). Transfection with p110b
shRNA led to diffuse cytoplasmic staining of RFC1 and a
decreased nuclear signal for RFC4 (Figure 2F). During
mitosis in control cells, RFC1 and RFC4 localized in the
vicinity of chromosomes, and p110b silencing reduced
the concentration of RFC1 surrounding chromosomes
(Figure 2G). These data conﬁrm the functional link of
p110b with RFC1 in vivo, and indicate that p110b expres-
sion is needed for correct RFC complex assembly and
localization.
RFC deletion affects DNA replication and repair similarly
to p110b knockdown
p110b is essential for S phase progression and DNA
repair, as is regulates correct binding of the molecular
clamps PCNA and RAD9 to chromatin (23,24). To
study whether p110b affects DNA replication and repair
by impairing RFC complex formation, we tested whether
RFC4 or p110b knockdown affected these responses simi-
larly. To analyse correct induction of the cell response to
DNA damage, we examined activation of the checkpoint
protein kinase 1 [Chk1, (29)]. After g-irradiation of
NIH3T3 cells, phospho-Chk1 levels were reduced both
in p110b- and in RFC4-depleted cells compared to
controls (Figure 3A).
To compare p110b and RFC function in DNA replica-
tion, we monitored expression of cyclin B, a mitotic cyclin
whose levels are increased throughout S phase (30).
We reduced p110b or RFC4 expression with shRNA in
cell cycle-synchronized NIH3T3 cells. Both treatments
downregulated cyclin B levels during S phase
(Figure 3B), reduced PCNA binding to chromatin
(Figure 3C), and altered S phase progression in trans-
fected cells (Figure 3D). Comparison of cell cycle
proﬁles in asynchronous cultures, however, showed that
RFC4 depletion (like that of p110b) (23) induced a slight
increase in S phase cell proportion that might result
from a delayed S phase entry and a prolonged S phase
duration due to reduced velocity of DNA replication (23)
(Figure 3D). Interference with RFC complex formation by
depletion of one of its subunits (RFC4) thus induced
defects in DNA repair, replication and cell cycle progres-
sion that were also observed after p110b deletion.
p110b is necessary for RFC-like complex function
We found that p110b depletion abrogates RFC1/RFC4
complex formation, PCNA association with RFC1 and
PCNA/RFC binding to chromatin (Figures 2B and 3C).
To determine whether p110b has a general function in
mediating RFC complex formation, we reduced p110b ex-
pression levels and analysed RFC–RAD17 association
after DNA damage as well as RFC–CTF18 complex for-
mation in mitosis. NIH3T3 cells were transfected with
p110b-speciﬁc shRNA (48 h) and g-irradiated, after
which we conﬁrmed reduction of p110b levels in lysates
(Figure 4A). In controls, Rad17 bound to RFC4 after ir-
radiation; however, p110b depletion reduced Rad17/
RFC4 interaction and in turn, Rad17 association with
Rad9 (Figure 4A). To study RFC–CTF18 complex
dependence on p110b expression, U2OS cells were trans-
fected with p110a or p110b siRNA and mitotic cells
enriched by colcemid treatment or culture plate shake-
off (mitotic cells are less adherent to the substrate).
We conﬁrmed that p110a or p110b silencing reduced the
expression of their targets, but not that of CTF18, RFC4
or SMC1 (Figure 4B). Depletion of p110b, but not of
p110a, decreased CTF18/RFC4 association (Figure 4B
and Supplementary Figure S1E).
RFC–CTF18 is a weak PCNA loader that controls the
velocity of replication fork and chromatid cohesion
(12,14,31–33). To test whether p110b deletion affects
RFC–CTF18 function, we analysed chromatid cohesion.
One consequence of reducing sister chromatid cohesion is
an increase in the inter-kinetochore (KT) distance in meta-
phase (34). Bipolar chromosome capture by microtubules
Figure 2. Continued
cytoplasmic and nuclear/chromatin controls. The graph shows RFC signal intensity in the chromatin of p110b knocked-down cells relative to that of
controls (100%). (F) NIH3T3 cells transfected with GFP plus p110b or control shRNA (48 h) were analysed by IF using RFC Ab; DNA was stained
with DAPI. Arrows indicate GFP-transfected cells (see insets). Nuclei are indicated with a dashed line. The graph shows nuclear RFC signal intensity
relative to total signal (100%). Mean± SEM, n=20. (G) NIH3T3 cells transfected as in (F) (24 h) were colcemid treated (16 h), released in medium
(1 h) and analysed as in (F). Bars=10 mm. * Student’s t-test P< 0.05; ** P< 0.01; *** P< 0.001. See Supplementary Figure S1.
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also increases this distance moderately, although to a
lesser extent than cohesion defects (34). Nonetheless, to
exclude potential bipolar attachment differences, we
compared the cells in metaphase when all chromatid
pairs show bipolar attachment. We transfected U2OS
cells with control, p110a or p110b siRNA, synchronized
them with colcemid (16 h), released them in medium (1 h),
and measured the inter-KT distance in metaphase
cells. Only p110b-depleted cells, but not control or
p110a-depleted cells showed increased inter-KT distance
(Figure 4C).
The mechanism that controls establishment of cohesion
is not fully understood, particularly in mammals, but
SMC1, SMC3, SCC1, SCC3 cohesins as well as ESCO2
(yeast Ctf7/Eco1), Wap1 and Pds5a are known to be ne-
cessary for chromatid cohesion (32,33). RFC–CTF18
controls progression of the replication fork along
cohesin-associated DNA, as well as cohesin binding and,
in turn, cohesion (4,32). To conﬁrm cohesion regulation
by p110b, we examined whether p110b silencing affected
the binding to DNA of one of the essential cohesins,
SMC1. In control and p110a siRNA-transfected cells,
CTF18 and SMC1 were found in the chromatin fraction;
in contrast, in p110b-depleted cells, SMC1 and CTF18
levels in chromatin were markedly reduced (Figure 4D).
These data show that p110b also affects RFC–CTF18
complex formation and cohesion, supporting a general
role for p110b in RFC complex assembly and function.
A conserved Lys/Asp motif in RFC1 is involved in the
p110b interaction
RAD17 and CTF18 are RFC1 homologs (4). After
sequence alignment of RFC1, RAD17 and CTF18, we
sought conserved sequences that might explain their
binding to p110b. We identiﬁed two potential conserved
regions that aligned in the three clamp loader subunits;
the ﬁrst was in the AAA+ATPase domain (residues 647–
658) and the second at theRFC-1C terminus (residues 836–
845). The residues in the AAA+domain are exposed in the
inner region of the RFC/PCNA structure (5) and corres-
pond to the ATPase P-loop that is part of the ATP-binding
site (35). We thus focused on the second region encom-
pasing RFC1 residues Lys841Asp842 (KD region;
Figure 5A). This region is conserved from yeast to
mammals and is exposed at the RFC/PCNA surface
(Supplementary Figure S2A and B) permitting protein–
protein interactions. RFC has several conserved domains;
the AAA+module is composed of RFC domains 1 and 2,
located beforeRFCdomain 3 (5). TheKDmotif (yeastKN)
is located in an exposed alpha helix at the end of the RFC
conserved domain 2 [(5), Supplementary Figure S2C].
We replaced the KD residues with non-polar residues to
generate the KD-RFC1 mutant (Figure 5A). To compare
p110b association with WT or mutant RFC1, we
performed in vitro transcription/translation and used
autoradiography to visualize RFC1 in complex with
immunoprecipitated p110b. Quantiﬁcation of autoradio-
graphs showed that p110b associated signiﬁcantly greater
with WT RFC1 than with the KD-RFC1 mutant
(Figure 5B). To determine whether the KD mutation
A B
shRNA
p-Chk1
RFC4
Actin
Cyclin B
RFC4
Actin
10 Gy 
NIH3T3 cells
Non irradiated
p110β sh
RFC4 sh
S Phase
NIH3T3 cells
G0/G1
MW 
100
50
37
75
37
50
MW 
37
50
50
100
37
100
37
MW 
+
+
+
+----
 pChk1 levels (10Gy) 
 Cyclin B1 in S
100
50
0
100
50
0
shRNA
p110β p110β
D
Time, h 0 5 7 9 
Control shRNA
RFC4 shRNA
p110β shRNA
40
20
0
C NIH3T3 cells, S phase
PCNA
RFC4
Tubulin
Histones
Cytoplasmic Nuclear Chromatin
p110β
Fraction
100
50
0
Pe
rc
en
t c
el
ls
 in
 S
 p
ha
se
 
Pe
rc
en
t s
ig
na
l
Pe
rc
en
t s
ig
na
l
Pe
rc
en
t c
hr
o
m
at
in
 
bo
un
d 
pr
o
te
in
 
n = 3 n = 3
n = 3
n = 3
 PCNA in Chromatin 
shRNA
Co
nt
ro
l
RF
C4
p1
10
β
Control
shRNA
RFC4 
shRNA
p110β 
shRNA
9 h post release
%S = 31
%S = 35
%S = 64
Ce
ll 
nu
m
be
r
p110β sh
RFC4 sh
+
+
+
+
p110β sh
RFC4 sh
Co
nt
ro
l
RF
C4
p1
10
β
Co
nt
ro
l
RF
C4
p1
10
β
(∗∗∗)
(∗)
(∗∗)
(∗∗)
(∗∗)
(∗∗)
(∗∗∗) (∗∗∗)
(∗∗)
Ctr shRNA
p110β 
shRNA
RFC4
shRNA
Ce
ll 
nu
m
be
r
---- ----
----
+
+--
-- +
+--
-- +
+--
--
%S = 23
%S = 20
%S = 23
DNA content
2n 4n
DNA content
2n 4n
Exponential
%S = 42
%S = 31
9 h post release
%S = 54
Figure 3. Downregulation of RFC or p110b alters S phase progression
and Chk1 activation. (A) NIH3T3 cells were transfected with control,
p110b or RFC4 shRNA (24 h), cells were irradiated (10Gy) or un-
treated, and cultured for 24 h. Phospho-Chk1 and protein expression
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affected only RFC1/p110b interaction, or also the RFC1/
RFC4 intersubunit interaction, we tested KD-RFC1
mutant binding to RFC4 in vitro (Figure 5C). Puriﬁed
WT RFC1 and KD-RFC1 associated to RFC4 at
similar levels (Figure 5C), ruling out an effect of this
region on RFC1/RFC4 intersubunit interactions. These
ﬁndings show that RFC1 binding to p110b is mediated
by the conserved KD residues. Localization of the KD
homolog residues in the Saccharomyces cerevisae RFC
crystal structure shows that they are proximal to the
CTD domain (Supplementary Figure S2C and D), which
regulates RFC complex assembly (10).
We also tested the effect of in vivo KD-RFC1 expres-
sion. We transfected NIH3T3 cells with WT RFC1 or the
KD mutant and studied complex formation. KD mutation
impaired RFC1/p110b association in vivo (Figure 5D).
Moreover, although in vitro association of the puriﬁed
KD-RFC1 mutant with RFC4 was similar to that of
WT RFC1 (Figure 5C), in vivo since RFC complex for-
mation (examined as RFC1 binding to RFC4) requires
RFC1 association to p110b, we detected a lower
interaction of RFC4 with KD-RFC1 (compared with
RFC1), leading to signiﬁcantly lower RFC complex for-
mation (Figure 5D). These results conﬁrm the idea that
the conserved KD residues in RFC1 mediate association
with p110b in vivo. Parallel to the reduction in RFC1/
p110b association in KD-RFC1 mutant-expressing
cells, we detected an increase in cytosolic KD-RFC1
(Figure 5E), indicating that RFC1/p110b association
affects RFC1 intracellular localization.
A p110 CT region is necessary for interaction with RFC1
Both p110a and p110b bind to RFC1 in vitro, suggesting
that the region involved in p110 association with RFC1 is
common to both p110 subunits. The RFC1 KD residues,
which mediate its association with p110, are polar and
exposed; to determine the p110b region that mediates
RFC1 association, we aligned p110a and p110b sequences
and searched for conserved, polar and exposed residues that
could establish this interaction. We pinpointed two regions
in p110a and p110b with exposed polar residues that are
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conserved across species (Figure 6A). The ﬁrst, with amotif
similar to that found in helicases, is located upstream of the
p110 Ras-binding domain (residues 141–150), whereas the
other, found in the p110 catalytic C terminus (residues
1031–1038) has a motif found in topoisomerase, RAD50,
Cdc45 and bromodomain-containing proteins (Figure 6A).
In each of these regions, we replaced polar with non-polar
residues to generate two p110b mutants (Figure 6A).
We synthesized WT RFC1, p110b and the p110b mutants,
and tested association of the puriﬁed products by IP and
autoradiography. p110b and p110b-mutant 1 associated
efﬁciently with RFC1; in contrast, p110b-mutant 2
showed signiﬁcantly less association (Figure 6B).
In NIH3T3 cells transfected with WT or mutant p110b,
we found reduced p110b-mutant 2 association with RFC1
(Figure 6C).
To analyse whether, as a result of impaired RFC1/
p110b complex formation, replication was impaired in
NIH3T3 cells expressing KD-RFC1 or p110b-mutant 2,
we depleted endogenous RFC1 and reconstituted expres-
sion using shRNA-resistant WT or KD-RFC1, or alter-
natively, we knocked-down p110b and reconstituted
cells with WT or p110b-mutant 2. We compared S phase
progression by BrdU pulse-chase, which permits
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measurement of the DNA replication rate (23). The results
conﬁrmed defective replication speed in RFC1- or p110b-
depleted cells, the correction mediated by reconstitution
with WT RFC1 or p110b, and the replication defect
of cells expressing RFC1-KD or p110b mutant 2
(Figure 6D). The results show that p110b CT residues
1031–1038 regulate its association with RFC1.
p110b deletion reduces RFC1–Ran interaction and affects
RFC1 nuclear localization
Cytoplasmic retention correlates with defects in RFC
function, since nuclear localization is necessary for RFC
complex formation and function (36,37). RFC1, RAD17
and CTF18 have nuclear localization signals (NLSs) that
mediate their Ran-GTPase-dependent nuclear localization
(37). Since p110b silencing impaired RFC complex forma-
tion and function as well as RFC1 nuclear localization
(Figure 2), we postulated that p110b association with
RFC1 subunits modulates RFC1 nuclear import.
We analysed whether RFC1 associates directly with
Ran-GTPase, by performing in vitro transcription/transla-
tion followed by autoradiography to test for Ran binding
to RFC1. In the absence of other proteins, puriﬁed RFC1
associated to Ran (Figure 7A). Direct RFC1 association
to Ran was not anticipated, as Ran association is
normally Imp mediated; in cytoplasm, NLS-containing
proteins bind to Imp-a and -b and are transported to
the nucleus, where Imp-b binds Ran-GTP to release the
NLS protein (38,39). To determine whether Ran also asso-
ciates with RFC1 in vivo, we immunoprecipitated RFC1
from NIH3T3 cells and tested its association with Ran in
WB. The results showed in vivo RFC1 association with
Ran (Figure 7B).
We studied the effect of p110b silencing on the RFC1/
Ran interaction in vivo. In control and p110a
siRNA-transfected U2OS cells, RFC1 associated with
Ran; in contrast, RFC1 association to Ran was
markedly reduced in p110b-depleted U2OS or NIH3T3
cells (Figure 7C), showing that p110b expression is neces-
sary for RFC1 interaction with Ran. p110b also has a
functional NLS (27). In cells, Ran could bind RFC1 in-
directly, through p110b. In our hands, however, puriﬁed
p110b alone or with p85b did not appear to associate
directly with Ran (Figure 7D) excluding that RFC1
binding to Ran reﬂects an indirect interaction via p110b.
Our ﬁndings show that puriﬁed RFC1 associates directly
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Figure 6. Continued
transfected with the p110b forms (48 h); p110b proteins and IP from
extracts prepared using anti-Myc Ab were tested in WB. The graph
shows RFC1 signal in p110b IP relative to maximum (as in B).
Mean±SEM (n=3). (D) NIH3T3 cells were depleted of endogenous
p110b or of RFC1 using shRNA, and reconstituted by transfection
with cDNA encoding WT or KR-p110b, or WT or RFC1-KD, respect-
ively. Protein expression was analysed in WB (top). The DNA replica-
tion rate was measured by BrdU incorporation (90min) in cells
collected at different times after resuspension in fresh medium. Bar
graphs show the percentage of cells in each cell cycle phase. White
asterisks indicate statistically signiﬁcant distribution differences
compared to control shRNA cells. Mean±SEM (n=3). * Student’s
t-test P< 0.05; *** P< 0.001.
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with Ran-GTPase in vitro, but in cells, this interaction
requires p110b expression, suggesting that only RFC1/
p110b complexes bind to Ran.
To evaluate whether RFC1 binds to active or inactive
forms of Ran in vivo, we took advantage of the ability of
Imp-b to bind Ran-GTP and used it as bait to pulldown
Ran-GTP. Imp-b pulled down RFC1, suggesting that
RFC1 binds to active Ran (Figure 7E, top). As an alter-
native approach, we transfected cells with Flag-WT Ran
or with the active Flag-Q69L-Ran mutant (40), and
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Figure 7. p110b expression is necessary for RFC1 association with Ran. (A) cDNAs encoding Flag-RFC1 and Flag-Ran were transcribed/translated
in vitro. Translated products and IP (Ab indicated) were resolved by SDS-PAGE. (B) NIH3T3 cells were lysed and endogenous RFC1/p110b
interaction examined by IP of RFC1 and WB. (C) NIH3T3 or U2OS cells were transfected with indicated shRNA or siRNA (48 h). Cells were
lysed and RFC1/Ran interactions were tested by IP/WB using appropriate Ab. (D) cDNAs encoding myc-p110b and Flag-Ran (±HA-p85b) were
synthesized in vitro. Translated products were analysed as in (A). (E) NIH3T3 cell extracts (top) were incubated with His-Imp-b beads and pulled
down proteins were analysed in WB. NIH3T3 cells were also transfected with WT or Q69L-Ran (48 h) (bottom). Extracts were immunoprecipitated
and analysed in WB as indicated. (F) Scheme of p110b action on RFC1. (G) 293T cells were transfected with Flag-RFC1-WT and p110b siRNA
(48 h). RFC complex formation was analysed by IP/WB. The graph shows RFC4 signal intensity in RFC1 IP relative to maximal (in controls, 100%;
mean±SEM, n=3). (H) 293T cells were transfected as in (G). RFC1 localization was determined using anti-Flag Ab and secondary Ab fused to
nanogold particles. Bars=1000 nm. The graph shows the percentage of RFC1 particles in the nucleus or cytosol. * Student’s t-test P< 0.05 (F) and
Fisher’s exact test (G) P< 0.001.
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examined the complexes by IP of Ran or of RFC1 and
detection of associated proteins in WB. Both WT and
active Ran bound similarly to RFC1 (Figure 7E) suggest-
ing that RFC1 might bind active and inactive Ran.
Our ﬁndings show that although RFC1 associates
directly with Ran-GTPase in vitro, this interaction
requires p110b expression in cells, suggesting that only
when it is in complex with p110b, RFC1 adopts a con-
formation and/or localization that allows RFC1/Ran
interaction. RFC1 association with Ran might regulate
its nuclear entry, and in turn RFC1 association with
other RFC subunits and effective chromatin binding by
molecular clamps (model in Figure 7F).
To conﬁrm the contribution of p110b to RFC1 nuclear
localization, we assessed Flag-RFC1 localization in control
or p110b siRNA-transfected 293T cells by transmission
electron microscopy (TEM). We ﬁrst conﬁrmed that
p110b silencing impairs RFC1/RFC4 association in these
cells (Figure 7G). TEM using a Flag primary antibody
showed that whereas in control cells RFC1 localized to
the nucleus, in p110b siRNA-transfected cells, a large per-
centage of the electron-opaque particles corresponding to
RFC1 were excluded from the nucleus (Figure 7H).
DISCUSSION
The assembly of homo- or heterotrimeric clamps in a ring
shape around DNA is a complex, ATP-consuming process
assisted by clamp loaders; RFC and RFC-like complexes
support this process. RFC complexes are formed by ﬁve
small subunits (RFC2–5) and a large RFC1 or RFC1-like
subunit.Herewe show that a p110bCTbinds to a conserved
Lys-Aspmotif present inRFC1 and theRFC1-like subunits
RAD17 and CTF18. This association is necessary for
RFC–RFC1, RFC–RAD17 and RFC–CTF18 complex
formation, as p110b depletion results in defective
assembly of all these complexes, in deﬁcient sliding clamp
loading onto chromatin, and in defective sliding
clamp-mediated cell responses. Indeed, interference
with RFC complex formation either by p110b or by
RFC4 silencing yielded similar DNA replication and
repair defects. In addition, p110bregulated RFC–
CTF18 mediated chromatid cohesion. We show that
p110b acts on RFC by regulating RFC1 association with
Ran-GTPase, resulting in RFC1 nuclear localization.
We show that a conserved RFC1 Lys-Asp (KD) motif
mediates association with p110b. Conserved Lys in RFC
subunits are proposed to mediate interaction with DNA;
however, these lysines are all located in the ﬁrst domain
(domain 1) of the AAA+ module (5) (Supplementary
Figure S2C). The KD motif involved in p110b association
is located in an exposed alpha helix at the end of the AAA+
module (domain 2) (5), just before another conserved
region in RFC subunits (domain 3, Supplementary
Figure S2C). Although the crystallized fragment of
S. cerevisae RFC1 (RFCA) lacks the extended unique
NT domain and most of the CTD, a small CTD region is
present in the crystal and is found in proximity to the
Lys-Asn peptide (corresponding to the KD motif in
mammals) (Supplementary Figure S2D). Although the
primary action of p110b is to facilitate RFC nuclear
import, it is possible that p110b interaction with the
RFC1 KD motif affects CTD structure, and in turn RFC
complex assembly (10). Since p110b binds to chromatin
(27), it might also regulate RFC binding to DNA.
RFC complexes are components of conserved DNA
molecular machines; there are four known RFC
complexes (RFC–RFC1, RFC–CTF18, RFC–RAD17
and RFC–ELG1). Although all RFC are able to load
PCNA onto chromatin, they have different requirements,
bind to different proteins and result in distinct RFC func-
tions in DNA homeostasis (4,12–14). Both p110a and
p110b bound to RFC1 in vitro, suggesting that the
region involved in p110 association with RFC1 is
present in both p110 subunits. The RFC1 KD residues,
which mediate its association with p110, are polar and
exposed. We aligned p110a and p110b sequences and
searched for polar, exposed residues that could mediate
p110 interaction with RFC1, and identiﬁed two candidate
sequences. Mutation of one of these (the ALGKSEE
EALK motif at the CT end of p110) abrogated interaction
with RFC1. Three-dimensional structural analysis of
the p85b/p110b heterodimer shows that in p110b (alpha
helix 11), this region forms part of the p110b regulatory
square that encompasses alpha helices 10, 11 and 12, as
well as the activation and catalytic loops (41). The p85b
nSH2 and cSH2 domains contact this regulatory square,
maintaining p110b in an inactive conformation (41). The
binding of p85b and RFC1 to the same region could
explain why p110b associates to RFC1 without p85b,
since p85b and RFC1 might compete for binding to this
region. RFC1/p110b interaction near the regulatory
square might affect p110b activity; future studies will
address this possibility. The polar nature of the regions
involved in RFC1/p110b association supports the likeli-
hood of a strong, apparently 1:1 electrostatic interaction
(Figure 1) between these molecules (Figure 7).
To deﬁne the ﬁrst event controlled by p110b in the RFC
cycle, we focused on the observation that p110b silencing
reduced the nuclear localization of RFC1. Given the mo-
lecular function of RFC complexes, appropriate nuclear
translocation of their subunits is crucial for their correct
assembly and function (36). Indeed, an interaction
between RFC4 and RIa regulates RFC4 nuclear localiza-
tion; disruption of this interaction alters cell proliferation
(28). RFC1, RAD17, CTF18 and p110b localize to the
nucleus (27,37). RFC-1 and RFC1-like subunits have
two conserved NLS sequences that might mediate
nuclear import of these proteins (37). Nonetheless, in the
canonical nuclear import mechanism, NLS-containing
proteins bind to Imps that mediate nuclear import. Once
in the nucleus, Imp-b binding to Ran-GTP mediates
release of NLS-containing proteins from the Imps
(38,39). We found that puriﬁed RFC1, but not p110b,
binds directly to Ran, suggesting that RFC1 might use
an alternative mechanism or combination of mechanisms
for its nuclear import, as described for other proteins
(39,42). We show that although RFC1 associates with
Ran in vitro, RFC1/Ran interaction (and RFC1 nuclear
localization) requires p110b expression in cells. p110b de-
pletion not only reduced RFC1 nuclear localization in
interphase; even in mitosis, p110b silencing reduced the
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RFC1 concentration near chromosomes (Figure 2G). As
Ran regulates protein proximity to chromosomes (43), de-
fective RFC1/Ran association after p110b silencing might
also impair RFC1 translocation to DNA. Although open
questions remain, our results suggest that the regulation
of RFC1 nuclear localization is a primary event by which
p110b controls correct RFC complex function.
The other ubiquitous PI3K isoform, p110a, interacted
with RFC1 in vitro, although no association was observed
in vivo. These ﬁndings concur with the primarily cytosolic
localization and function of p110a, which controls
receptor-induced plasma membrane phosphoinositide
production; p110b also binds to membrane receptors
and regulates phosphoinositide production, but a large
fraction of p110b localizes in the nucleus and is able to
bind DNA (22,23,27).
Our observations support a general function for p110b
in the control of distinct RFC complexes. We show that
p110b deletion induced a phenotype similar to that of
RFC4 deletion in S phase progression and DNA repair
checkpoint activation. Based on the role of of p110b in
RFC–CTF18 complex formation, we postulate that cell
functions controlled by this RFC would also be affected
by p110b deletion. RFC–CTF18 regulates elongation as
well as cohesion of sister chromatids (33). Although the
mechanism that controls the establishment of cohesion is
not fully understood (33,44), it seems clear that the RFC–
CTF18 complex regulates cohesion, at least in yeast
(12,31,32). We show that the inter-KT distance in mam-
malian cell metaphase is markedly higher in p110b-
depleted cells than in controls, an indication of defective
cohesion; a similar phenotype is found in cells depleted of
SMC1, one of the critical cohesins (34). We also examined
SMC1 binding to chromatin, which was reduced after
p110b silencing. These results indicate that p110b-depleted
cells have defective chromatid cohesion.
Sliding clamp proteins girdle DNA and act as mobile
platforms for organizing DNA processes. Aberrations in
DNA stability and maintenance are associated with onco-
genesis and age-related diseases (1). The study of the mo-
lecular mechanisms that control DNA metabolism and
the proteins involved will yield new targets for prevention
and therapy for these diseases. Our observations support
the conclusion that p110b has a general function in
control of RFC/RFC-like complex functions, thereby pro-
tecting genomic stability.
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